Metabolic tissue characterization in patients with acute myocardial infarction with positron tomography
Creators
- 1. UCLA School of Medicine, Los Angeles, CA
Description
Identification of myocardium at risk in acute myocardial infarction (AMI) is important for patient management. The authors previously demonstrated in animals that reversible tissue injury can be identified with PET and tracers of metabolism. To characterize reginal metabolism in AMI, 12 patients were studied <72 hours after onset of symptoms with positron tomography (PET). Regional wall motion (WM) was assessed by 2D echocardiography at the time of the PET study and again 6 weeks later. Myocardial blood flow (MBF) and exogenous glucose utilization were measured with N-13 ammonia and F-18 deoxyglucose in 5 LV segments in each patient and compared to regional WM. MBF was decreased in 29 LV segments. The irreversible tissue injury can be identified early in patients with AMI. PET frequently reveals persistent glucose utilization in ''infarcted'' myocardium when studied within 72 hours after AMI. Persistent exogenous glucose utilization detected by PET early after AMI can identify viable but jeopardized myocardium and may predict subsequent functional recovery
Additional details
Publishing Information
- Journal Title
- J. Nucl. Med.
- Journal Volume
- 26
- Journal Issue
- 5
- Series
- J. Nucl. Med.
- Journal Page Range
- 87
- ISSN
- 0022-3123
- CODEN
- JNMEA
Conference
- Title
- 32. annual meeting of the Society of Nuclear Medicine.
- Dates
- 2-5 Jun 1985.
- Place
- Houston, TX (USA).
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 19022431
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S60: APPLIED LIFE SCIENCES;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- BLOOD FLOW; DIAGNOSIS; DYNAMIC FUNCTION STUDIES; FLUORODEOXYGLUCOSE; GLUCOSE; HEART; LABELLING; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIUM; POSITRON COMPUTED TOMOGRAPHY
- Descriptors DEC
- ALDEHYDES; ANTIMETABOLITES; BODY; CARBOHYDRATES; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COMPUTERIZED TOMOGRAPHY; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; HEXOSES; MONOSACCHARIDES; MUSCLES; ORGANIC COMPOUNDS; ORGANS; SACCHARIDES; TOMOGRAPHY
Optional Information
- Secondary number(s)
- CONF-850611--.